Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study

PURPOSE: Cutaneous melanoma is among the fastest growing malignancies in Norway and ultraviolet radiation (UVR) exposure is the primary environmental risk factor. Immunomodulating drugs can increase skin photosensitivity and suppress immune responses, and by such mechanisms influence melanoma risk....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Epidemiol
Autors principals: Berge, Leon Alexander Mclaren, Andreassen, Bettina Kulle, Stenehjem, Jo Steinson, Heir, Trond, Karlstad, Øystein, Juzeniene, Asta, Ghiasvand, Reza, Larsen, Inger Kristin, Green, Adele C, Veierød, Marit Bragelien, Robsahm, Trude Eid
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755337/
https://ncbi.nlm.nih.gov/pubmed/33376408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CLEP.S269446
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars